UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Total revenue	$ 608.9	$ 511.4	$ 1,734.4	$ 1,360.0
Total cost of revenue	300.2	263.1	866.4	733.2
Gross profit	308.7	248.3	868.0	626.8
Operating expenses:
Selling, general and administrative	141.3	114.6	407.9	338.2
Research and development	52.1	48.3	162.7	140.9
Other charges, net	2.1	4.2	9.5	12.2
Total operating expenses	195.5	167.1	580.1	491.3
Operating income	113.2	81.2	287.9	135.5
Interest and other income (expense), net	(4.4)	(5.9)	(13.8)	(15.4)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	108.8	75.3	274.1	120.1
Income tax provision	20.7	20.0	69.5	30.0
Consolidated net income	88.1	55.3	204.6	90.1
Net income attributable to noncontrolling interests in consolidated subsidiaries	1.0	1.0	3.2	1.2
Net income attributable to Bruker Corporation	$ 87.1	$ 54.3	$ 201.4	$ 88.9
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.58	$ 0.35	$ 1.33	$ 0.58
Diluted (in dollars per share)	$ 0.57	$ 0.35	$ 1.32	$ 0.57
Weighted average common shares outstanding:
Basic (in shares)	151.4	153.2	151.5	153.7
Diluted (in shares)	152.8	154.3	153.0	154.8
Comprehensive income	$ 73.1	$ 64.0	$ 188.1	$ 110.1
Less: Comprehensive income attributable to noncontrolling interests	0.7	1.4	0.9	1.5
Less: Comprehensive loss attributable to redeemable noncontrolling interest	0.0	0.0	0.0	(0.5)
Comprehensive income attributable to Bruker Corporation	72.4	62.6	187.2	109.1
Product
Total revenue	508.3	419.6	1,441.2	1,111.6
Total cost of revenue	243.5	210.3	700.4	584.1
Service
Total revenue	99.0	90.0	287.8	244.3
Total cost of revenue	56.5	52.6	165.3	148.4
Other
Total revenue	1.6	1.8	5.4	4.1
Total cost of revenue	$ 0.2	$ 0.2	$ 0.7	$ 0.7